← brief for 2026-09-01 · Slowing decline

Incretin-Based Therapies Versus Bariatric and Metabolic Surgery for Obesity and Type 2 Diabetes Mellitus: A Head-to-Head Systematic Review of Glycaemic, Cardiovascular, Hepatic, Weight, and Quality-of-Life Outcomes.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

A systematic review comparing GLP-1 weight loss drugs against weight loss surgery for obesity and type 2 diabetes. It measured blood sugar, heart, liver, weight and quality of life results. It did not look at kidney function at all, so it says nothing about slowing kidney decline. Dropped as off topic for this digest.

Who did this work

Alsayed O · Jarai MZ · Khan S · Sandal M

Source

Article · PubMed, the drug frontier · 2026 Aug 1
https://pubmed.ncbi.nlm.nih.gov/42677221/